Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 128 articles: HTML format

Single Articles

June 2024
1. SHIINA Y, Nagao M, Itatani K, Shimada E, et al
   4D flow MRI-derived energy loss and RV workload in adults with tetralogy of Fallot.
   J Cardiol. 2024;83:382-389.
   PubMed     Abstract available
   
   
   May 2024
2. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
   Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
   J Cardiol. 2024;83:313-317.
   PubMed     Abstract available
   
   
   April 2024
3. BUTTER L, Haase-Fielitz A, Zanker M, Becher G, et al
   Cluster analysis of volatile organic compounds - a pilot study in patients with severe acute decompensated heart failure.
   J Cardiol. 2024 Apr 13:S0914-5087(24)00062-5. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
4. MAKHOUL GW, Mustafa A, Wei C, Ling J, et al
   Heart failure - An unexplored risk factor for infective endocarditis after pacemaker implantation.
   J Cardiol. 2024 Apr 5:S0914-5087(24)00061-3. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
5. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
   Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
   J Cardiol. 2024;83:228-235.
   PubMed     Abstract available
   
   
   March 2024
6. OHIRA T, Eguchi E, Hayashi F, Kinuta M, et al
   Epidemiology of cardiovascular disease in Japan: An overview study.
   J Cardiol. 2024;83:191-200.
   PubMed     Abstract available
   
   
   
7. ONODA H, Imamura T, Ueno H, Oshima A, et al
   Prognostic impact of elevated erythropoietin levels in patients with severe aortic stenosis receiving trans-catheter aortic valve implantation.
   J Cardiol. 2024;83:149-154.
   PubMed     Abstract available
   
   
   February 2024
8. YAKU H, Fudim M, Shah SJ
   Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
   J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
9. SHIBATA T, Matsumoto S, Muramoto T, Matsukawa M, et al
   Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic - Observational cohort study using Japanese administrative data.
   J Cardiol. 2024 Feb 2:S0914-5087(24)00011-X. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   December 2023
10. SATO K, Kamiya K, Hamazaki N, Nozaki K, et al
    Association of sarcopenia defined by different skeletal muscle mass measurements with prognosis and quality of life in older patients with heart failure.
    J Cardiol. 2023 Dec 20:S0914-5087(23)00305-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    November 2023
11. HEIDENREICH P
    Heart failure management guidelines: New recommendations and implementation.
    J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    October 2023
12. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
    Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
    J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
13. POL T, Karlstrom P, Lund LH
    Heart failure registries - Future directions.
    J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
14. SI J, Ding Z, Hu Y, Zhang X, et al
    Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
15. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
    Early mobilization for acute heart failure: A scoping and a systematic review.
    J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    September 2023
16. SEO M, Watanabe T, Yamada T, Morita T, et al
    The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
    J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
17. MATSUDA H, Kuragaichi T, Sato Y
    Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
    J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    August 2023
18. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
    The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
    J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
19. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
    The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
    J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
20. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
21. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    PubMed     Abstract available
    
    
    July 2023
22. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
23. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    PubMed     Abstract available
    
    
    
24. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    PubMed     Abstract available
    
    
    
25. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    PubMed     Abstract available
    
    
    
26. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available
    
    
    June 2023
27. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
28. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
29. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    May 2023
30. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
31. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    
    
    
    
32. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available
    
    
    
33. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    PubMed     Abstract available
    
    
    April 2023
34. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
35. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
36. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed     Abstract available
    
    
    
37. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed     Abstract available
    
    
    March 2023
38. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
39. IMAMURA T, Narang N, Kinugawa K
    Clinical implications of remote dielectric sensing system to estimate lung fluid levels.
    J Cardiol. 2023;81:276-282.
    PubMed     Abstract available
    
    
    February 2023
40. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
41. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
42. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
43. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    December 2022
44. KINUGAWA K, Matsukawa M, Nakamura Y, Aihara M, et al
    Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
    J Cardiol. 2022 Dec 29:S0914-5087(22)00323-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
45. SHIMOMOTO R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, et al
    Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
    J Cardiol. 2022 Dec 13:S0914-5087(22)00312-4. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
46. CHIBA Y, Iwano H, Aoyagi H, Tamaki Y, et al
    Associations of right ventricular pulsatile load and cardiac power output to clinical outcomes in heart failure: Difference from systemic circulation.
    J Cardiol. 2022 Dec 8:S0914-5087(22)00311-2. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
47. OHTE N, Tanaka A, Kitada S, Yamada T, et al
    Influence of left ventricular ejection fraction on the reduction in N-terminal pro-brain natriuretic peptide by canagliflozin in patients with heart failure and type 2 diabetes: a sub analysis of the CANDLE trial.
    J Cardiol. 2022 Dec 5:S0914-5087(22)00295-7. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
48. NAMBA T, Masaki N, Hitomi Y, Ishinoda Y, et al
    Association of serum nitric oxide metabolite level with mortality in patients undergoing coronary angiography.
    J Cardiol. 2022;80:578-584.
    PubMed     Abstract available
    
    
    
49. TSUDA E, Ito Y, Kato Y, Sakaguchi H, et al
    Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
    J Cardiol. 2022;80:557-562.
    PubMed     Abstract available
    
    
    November 2022
50. KIDA K, Miyajima I, Suzuki N, Greenberg BH, et al
    Nutritional Management of Heart Failure.
    J Cardiol. 2022 Nov 9. pii: S0914-5087(22)00272.
    PubMed     Abstract available
    
    
    
51. ZHANG T, Gao Z, Chen K
    Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    J Cardiol. 2022;80:423-431.
    PubMed     Abstract available
    
    
    October 2022
52. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available
    
    
    
53. IMAMURA T
    Clinical implication of difficulty initiating sleep in patients with heart failure.
    J Cardiol. 2022 Oct 15. pii: S0914-5087(22)00257.
    PubMed    
    
    
    
54. HASHIMOTO S, Kitakata H, Kohsaka S, Fujisawa D, et al
    Confidence in self-care after heart failure hospitalization.
    J Cardiol. 2022 Oct 11. pii: S0914-5087(22)00254.
    PubMed     Abstract available
    
    
    September 2022
55. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    J Cardiol. 2022 Sep 24. pii: S0914-5087(22)00223.
    PubMed     Abstract available
    
    
    
56. ISHIZAKA S, Iwano H, Tsujinaga S, Murayama M, et al
    Determinants of exercise capacity in patients with heart failure without left ventricular hypertrophy.
    J Cardiol. 2022 Sep 16. pii: S0914-5087(22)00227.
    PubMed     Abstract available
    
    
    
57. MAEKAWA Y, Takamisawa I, Takano H, Takayama M, et al
    Percutaneous transluminal septal myocardial ablation: past, present, and future.
    J Cardiol. 2022;80:211-217.
    PubMed     Abstract available
    
    
    August 2022
58. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available
    
    
    
59. HATANO M, Jimba T, Fujiwara T, Tsuji M, et al
    Late-onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature.
    J Cardiol. 2022;80:110-115.
    PubMed     Abstract available
    
    
    
60. ISHIDO M
    Current status and challenges of Pediatric heart transplantation in Japan.
    J Cardiol. 2022;80:145-148.
    PubMed     Abstract available
    
    
    June 2022
61. KARIM A, Muhammad T, Shah I, Khan J, et al
    A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure.
    J Cardiol. 2022 Jun 21. pii: S0914-5087(22)00152.
    PubMed     Abstract available
    
    
    
62. AMISAKI R, Kato M, Fujiyama M, Matsuda E, et al
    Difficulty initiating sleep in patients with heart failure: Impact of left atrial pressure.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00136.
    PubMed     Abstract available
    
    
    
63. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    PubMed     Abstract available
    
    
    
64. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    PubMed     Abstract available
    
    
    
65. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    PubMed     Abstract available
    
    
    April 2022
66. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    PubMed     Abstract available
    
    
    March 2022
67. IWANO H, Utsunomiya H, Shibayama K, Tanaka H, et al
    Results of PRospect trial to Elucidate the utility of EchocarDiography-based Cardiac ouTput in acute heart failure (PREDICT).
    J Cardiol. 2022 Mar 17. pii: S0914-5087(22)00055.
    PubMed     Abstract available
    
    
    
68. NAKAI T, Ikeya Y, Kogawa R, Okumura Y, et al
    Cardiac resynchronization therapy: Current status and near-future prospects.
    J Cardiol. 2022;79:352-357.
    PubMed     Abstract available
    
    
    
69. OKI T, Ishii S, Takigami Y, Eda Y, et al
    Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    J Cardiol. 2022;79:358-364.
    PubMed     Abstract available
    
    
    February 2022
70. YOSHIKAWA T
    New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?
    J Cardiol. 2022 Feb 25. pii: S0914-5087(22)00031.
    PubMed     Abstract available
    
    
    
71. SATO Y, Yoshihisa A, Takeishi R, Ohara H, et al
    B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00026.
    PubMed     Abstract available
    
    
    
72. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available
    
    
    January 2022
73. MIYANAGA S, Komukai K, Kubota T, Shirasaki K, et al
    Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.
    J Cardiol. 2022;79:15-20.
    PubMed     Abstract available
    
    
    
74. WANG S, Jiang C, Zhao L, Sun S, et al
    Metabolic maturation during postnatal right ventricular development switches to heart-contraction regulation due to volume overload.
    J Cardiol. 2022;79:110-120.
    PubMed     Abstract available
    
    
    
75. BRONS M, Rutten FH, Zuithoff NPA, Oerlemans MIFJ, et al
    Disease management with home telemonitoring aimed at substitution of usual care in the Netherlands: Post-hoc analyses of the e-Vita HF study.
    J Cardiol. 2022;79:1-5.
    PubMed     Abstract available
    
    
    December 2021
76. YAKU H, Kaneda K, Kitamura J, Kato T, et al
    Kampo medicine for the holistic approach to older adults with heart failure.
    J Cardiol. 2021 Dec 30. pii: S0914-5087(21)00366.
    PubMed     Abstract available
    
    
    
77. KAKUTANI N, Yokota T, Fukushima A, Obata Y, et al
    Impact of citrus fruit intake on the mental health of patients with chronic heart failure.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00359.
    PubMed     Abstract available
    
    
    
78. SHINOMIYA H, Koyama S, Tanada Y, Takahashi N, et al
    Corrigendum to "Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure" 65 (2015) 526-530 6.
    J Cardiol. 2021 Dec 22. pii: S0914-5087(21)00317.
    PubMed    
    
    
    
79. FUKATA M, Yamasaki H, Sai E, Ogawa K, et al
    Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    J Cardiol. 2021 Dec 19. pii: S0914-5087(21)00315.
    PubMed     Abstract available
    
    
    
80. SAITO C, Jujo K, Kametani M, Arai K, et al
    Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients.
    J Cardiol. 2021 Dec 18. pii: S0914-5087(21)00279.
    PubMed     Abstract available
    
    
    
81. SAKU K, Yokota S, Nishikawa T, Kinugawa K, et al
    Interventional heart failure therapy: A new concept fighting against heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00339.
    PubMed     Abstract available
    
    
    
82. ODAJIMA S, Tanaka H, Fujimoto W, Kuroda K, et al
    Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00357.
    PubMed     Abstract available
    
    
    
83. MINATOGUCHI S
    Heart failure and its treatment from the perspective of sympathetic nerve activity.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00337.
    PubMed     Abstract available
    
    
    
84. YAMAMOTO M, Ishizu T, Seo Y, Nakagawa D, et al
    Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00342.
    PubMed     Abstract available
    
    
    
85. NISHIDA H, Ota T, Onsager D, Grinstein J, et al
    Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure.
    J Cardiol. 2021 Dec 8. pii: S0914-5087(21)00320.
    PubMed     Abstract available
    
    
    
86. OISHI H, Okumura T, Ohashi K, Kimura Y, et al
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    J Cardiol. 2021;78:524-532.
    PubMed     Abstract available
    
    
    November 2021
87. HARADA T, Kagami K, Kato T, Obokata M, et al
    Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 29. pii: S0914-5087(21)00313.
    PubMed     Abstract available
    
    
    
88. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed     Abstract available
    
    
    
89. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed     Abstract available
    
    
    
90. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed     Abstract available
    
    
    October 2021
91. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    
    
    
    September 2021
92. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available
    
    
    August 2021
93. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    PubMed     Abstract available
    
    
    
94. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available
    
    
    June 2021
95. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available
    
    
    
96. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available
    
    
    
97. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available
    
    
    
98. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available
    
    
    May 2021
99. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available
    
    
    
100. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
     Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
     J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
     PubMed     Abstract available
     
     
     April 2021
101. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
     Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
     J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
     PubMed     Abstract available
     
     
     
102. NAKAMURA T, Tsujita K
     Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
     J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
     PubMed     Abstract available
     
     
     
103. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
     Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
     J Cardiol. 2021;77:408-416.
     PubMed     Abstract available
     
     
     March 2021
104. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
     Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
     J Cardiol. 2021;77:254-262.
     PubMed     Abstract available
     
     
     
105. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
     Mechanical Circulatory Support in Women.
     J Cardiol. 2021;77:209-216.
     PubMed     Abstract available
     
     
     February 2021
106. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
     Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
     J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
     PubMed     Abstract available
     
     
     
107. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
     Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
     J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
     PubMed     Abstract available
     
     
     
108. SOEDA T, Okura H, Saito Y, Nakao K, et al
     Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
     J Cardiol. 2021;77:139-146.
     PubMed     Abstract available
     
     
     
109. NAITO Y, Masuyama T, Ishihara M
     Iron and cardiovascular diseases.
     J Cardiol. 2021;77:160-165.
     PubMed     Abstract available
     
     
     January 2021
110. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
     Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
     J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
     PubMed     Abstract available
     
     
     
111. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
     Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
     J Cardiol. 2021;77:10-16.
     PubMed     Abstract available
     
     
     
112. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
     Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
     J Cardiol. 2021;77:30-40.
     PubMed     Abstract available
     
     
     December 2020
113. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
     Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
     J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
     PubMed     Abstract available
     
     
     
114. NATANZON SS, Mazin I
     Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
     J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
     PubMed    
     
     
     
115. IZUMIDA T, Imamura T
     The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
     J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
     PubMed    
     
     
     
116. IZUMIDA T, Imamura T
     Sarcopenia in patients with cardiovascular disease.
     J Cardiol. 2020;76:636.
     PubMed    
     
     
     November 2020
117. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
     Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
     J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
     PubMed     Abstract available
     
     
     
118. CHANG WT, Lin CH, Hong CS, Liao CT, et al
     The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
     J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
     PubMed     Abstract available
     
     
     
119. HATA R, Kato T, Yaku H, Morimoto T, et al
     Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
     J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
     PubMed     Abstract available
     
     
     October 2020
120. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
     Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
     J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
     PubMed     Abstract available
     
     
     September 2020
121. KOBAYASHI S, Yoshiga Y, Yano M
     Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
     J Cardiol. 2020;76:323-324.
     PubMed    
     
     
     May 2020
122. SATO K, Takahashi J, Hao K, Miyata S, et al
     Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
     J Cardiol. 2020;75:465-472.
     PubMed     Abstract available
     
     
     April 2020
123. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
     Grey areas and open questions in neprilysin inhibition.
     J Cardiol. 2020;75:462-463.
     PubMed    
     
     
     
124. CHANG HY, Yin WH
     Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
     J Cardiol. 2020;75:463-464.
     PubMed    
     
     
     
125. LIANG Y, Wang J, Yu Z, Zhang M, et al
     Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
     J Cardiol. 2020;75:432-438.
     PubMed     Abstract available
     
     
     March 2020
126. CHANG HY, Chen KC, Fong MC, Feng AN, et al
     Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
     J Cardiol. 2020;75:233-241.
     PubMed     Abstract available
     
     
     September 2019
127. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
     Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
     J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
     PubMed     Abstract available
     
     
     
128. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
     Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
     J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.